Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.050
+0.070 (7.13%)
At close: May 12, 2025, 4:00 PM
1.050
0.00 (0.01%)
After-hours: May 12, 2025, 7:24 PM EDT
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $63.60 million as of May 12, 2025. Its market cap has decreased by -66.71% in one year.
Market Cap
63.60M
Enterprise Value
-138.22M
1-Year Change
-66.71%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $63.60M, a decrease of -89.72%. That is a compound annual growth rate of -44.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 59.37M | -42.55% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |